Nominating committees are facing heightened scrutiny from investors and other governance specialists who are intensifying their focus on board composition and director qualifications. This is driven by several developments, such as the push for greater diversity in the boardroom (including recent comments by U.S. Securities and Exchange Commission Chair White indicating that she’s requested a review of existing company disclosures on board diversity), [1] increased investor and company interest in board assessments, the growing influence of hedge fund activists who may question board performance and the emergence of, according to many governance specialists, proxy access [2] as a new leading practice.